Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis
Allergy2017Vol. 73(1), pp. 187–195
Citations Over TimeTop 10% of 2017 papers
Oliver Pfaar, Sonja Lang, Ursula Pieper‐Fürst, A. Astvatsatourov, F. Gerich, L. Klimek, Matthias Krämer, Y. Reydelet, Kija Shah‐Hosseini, Ralph Mösges
Abstract
Booster AIT using tyrosine-absorbed allergoids containing the adjuvant MPL® effectively prevents re-occurrence of symptoms in patients with grass pollen-induced ARC.
Related Papers
- → Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence(2012)179 cited
- → Epicutaneous allergen administration: A novel approach for allergen-specific immunotherapy?(2009)24 cited
- → The allergen specificity of allergen immunotherapy—doubt no more(2019)9 cited
- → Multiple-allergen And Single-allergen Immunotherapy Strategies In Polysensitized Patients: Looking At The Published Evidence(2012)9 cited
- Allergen immunotherapy: the good, the bad, and the unknown.(2014)